美時化學製藥股份有限公司 2025 Sustainability Report

Report summary

• This page summarizes the 2025 sustainability report and ESG report PDF source for 美時化學製藥股份有限公司 (1795).
• The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
• third-party information includes assurance body 正大聯合會計師事務所 Grant Thornton Taiwan; this can be used to review report verification, assurance, and disclosure standards.
• Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company

美時化學製藥股份有限公司（1795）

Reporting Year

2025

Disclosure Period

2025/01/01 to 2025/12/31

Industry

生技醫療業

Third-party information

third-party information includes assurance body 正大聯合會計師事務所 Grant Thornton Taiwan

PDF source

The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)

2,495

Reporting Boundary：已完成母公司,盤查範圍為台灣、韓國、其他亞洲。其他亞洲包含新加坡、印度、泰國、菲律賓、越南、馬來西亞、中國、日本、香港等營運據點。

Verification：是

Scope 2 Emissions (Tons CO2e)

13,818

Reporting Boundary：已完成母公司,盤查範圍為台灣、韓國、其他亞洲。其他亞洲包含新加坡、印度、泰國、菲律賓、越南、馬來西亞、中國、日本、香港等營運據點。

Verification：是

Scope 3 Emissions (Tons CO2e)

17,077

Reporting Boundary：僅盤查台灣的 分類第一項僅盤查主要原料非全部原物料 第三項 第四項

Verification：否

Energy Management

Renewable Energy Share

Not disclosed

Reporting Boundary：Not disclosed

Verification：Not disclosed

Water Management

Water Use (Metric Tons)

133,885

Reporting Boundary：統計範疇為台灣南投廠、韓國公州廠及韓國鄉南廠。

Verification：Not disclosed

Board of Directors

Board Seats (Including Independent Directors)

11

Independent Director Seats

3

Female Director Ratio

45.5%

Ranked 3 among 61 companies in the same industry (percentile 97).

Board Meeting Attendance Rate

91.7%

Ranked 49 among 61 companies in the same industry (percentile 18).

Independent Director Ratio

27.3%

Ranked 60 among 61 companies in the same industry (percentile 0).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

• Compare how 美時化學製藥股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
• Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
• Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.